CVS Health’s revenue beat masks a miss on full-year profit guidance

A revenue beat with a profit guidance miss signals stronger top-line performance but weaker-than-expected profitability. CVS Health reported Q4 revenues of $105.7 billion, up 8.2% year on year. The revenue figure exceeded analysts’ expectations by 2%. The company missed analysts’ full-year EPS guidance estimates. Investors are prioritizing profit expectations over revenue growth in the short term. The stock is up 1.2% since reporting, indicating muted positive sentiment despite the profit guidance miss.